The Journal of Biomarkers in Drug Development adopts double blind review process which is closely monitored by the editors. Editors undertake editorial review to assess the quality and type of submission before sending it to the review process. Manuscripts not meeting the scientific standards will not be considered for the reviewing process. Authors are expected to pay attention to the instructions for authors and also indicate the category in which they are publishing if it is not a research article. Editors will also check the readability, grammatical usage and may ask for resubmission if papers fare poorly in these parameters. The final decision is taken by the chief editor by considering all comments and suggestions provided by the reviewers. All articles published in the journal are subject to a rigorous peer review process.